← Return to John Hopkins Webinar on transplant recipients and vaccines

Discussion

John Hopkins Webinar on transplant recipients and vaccines

Transplants | Last Active: Jan 13, 2022 | Replies (141)

Comment receiving replies
@luckonetj

Evidently Tacrolimus is a prophylactic for Covid 19 in preventing sever infection.
Tacrolimus is immunosuppressive by inhibiting calcineurin, and suppressing the early phase of T-cell activation, and the expression of many cytokines (IL-2, IL-4, TNF-α and IFN-γ) that are needed in the activation of the cellular immune response, possibly preventing a cytokine storm as observed in severe COVID-19.Jun 27, 2020
https://www.ncbi.nlm.nih.gov › pmc
Calcineurin inhibitors revisited: A new paradigm for COVID-19? - NCBI - NIH

Jump to this post


Replies to "Evidently Tacrolimus is a prophylactic for Covid 19 in preventing sever infection. Tacrolimus is immunosuppressive by..."

What about cellcept/mycophelonate? Does it also prevent a severe immune response to covid 19